Journal
BIOTECHNOLOGY LETTERS
Volume 29, Issue 7, Pages 995-1003Publisher
SPRINGER
DOI: 10.1007/s10529-007-9346-1
Keywords
bacteriophage; therapy; sequence; gene; toxin; virulence factor
Categories
Ask authors/readers for more resources
The challenges for successful launching of a profitable phage therapeutic product include intellectual property rights, safety issues, reproducibility, stability and robustness of the product. A successful and marketable product would be a highly purified bacteriophage preparation containing one or several fully characterized phages, accompanied by optimized methods of administration and backed up by properly controlled efficacy and safety studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available